Patents by Inventor Eugene Marie Jozef Jans

Eugene Marie Jozef Jans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pregelatinized starch in a controlled release formulation
    Patent number: 8591945
    Abstract: The present invention concerns the use of pregelatinized starch to prevent dose-dumping from a hydrophilic controlled release formulation. It also concerns a hydrophilic controlled release formulation, more in particular a hydrophilic controlled release matrix formulation, and solid dosage forms prepared therefrom, preferably for once daily oral administration. The hydrophilic controlled release formulation comprises pregelatinized starch, one or more active ingredients, one or more viscous hydrophilic polymers and optionally pharmaceutically acceptable formulating agents. Preferred hydrophilic polymers include hydroxypropyl cellulose and hydroxypropyl methylcellulose.
    Type: Grant
    Filed: April 1, 2009
    Date of Patent: November 26, 2013
    Assignee: Janssen Pharmaceutica, N.V.
    Inventors: Roger Petrus Gerebern Vandecruys, Eugene Marie Jozef Jans
  • Pregelatinized Starch In A Controlled Release Formulation
    Publication number: 20090191266
    Abstract: The present invention concerns the use of pregelatinized starch to prevent dose-dumping from a hydrophilic controlled release formulation. It also concerns a hydrophilic controlled release formulation, more in particular a hydrophilic controlled release matrix formulation, and solid dosage forms prepared therefrom, preferably for once daily oral administration. The hydrophilic controlled release formulation comprises pregelatinized starch, one or more active ingredients, one or more viscous hydrophilic polymers and optionally pharmaceutically acceptable formulating agents. Preferred hydrophilic polymers include hydroxypropyl cellulose and hydroxypropyl methylcellulose.
    Type: Application
    Filed: April 1, 2009
    Publication date: July 30, 2009
    Applicant: JANSSEN PHARMACEUTICA N.V.
    Inventors: Roger Petrus Gerebern Vandecruys, Eugene Marie Jozef Jans
  • Pregelatinized starch in a controlled release formulation
    Publication number: 20040062805
    Abstract: The present invention concerns the use of pregelatinized starch to prevent dose-dumping from a hydrophilic controlled release formulation. It also concerns a hydrophilic controlled release formulation, more in particular a hydrophilic controlled release matrix formulation, and solid dosage forms prepared therefrom, preferably for once daily oral administration. The hydrophilic controlled release formulation comprises pregelatinized starch, one or more active ingredients, one or more viscous hydrophilic polymers and optionally pharmaceutically acceptable formulating agents. Preferred hydrophilic polymers include hydroxypropyl cellulose and hydroxypropyl methylcellulose.
    Type: Application
    Filed: September 30, 2003
    Publication date: April 1, 2004
    Inventors: Roger Petrus Gerebern Vandecruys, Eugene Marie Jozef Jans
  • Pregelatinized starch in a controlled release formulation
    Patent number: 6667060
    Abstract: The present invention concerns the use of pregelatinized starch to prevent dose-dumping from a hydrophilic controlled release formulation. It also concerns a hydrophilic controlled release formulation, more in particular a hydrophilic controlled release matrix formulation, and solid dosage forms prepared therefrom, preferably for once daily oral administration. The hydrophilic controlled release formulation comprises pregelatinized starch, one or more active ingredients, one or more viscous hydrophilic polymers and optionally pharmaceutically acceptable formulating agents. Preferred hydrophilic polymers include hydroxypropyl cellulose and hydroxypropyl methylcellulose.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: December 23, 2003
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Roger Petrus Gerebern Vandecruys, Eugene Marie Jozef Jans
  • Cisapride extended release
    Patent number: 6274599
    Abstract: The present invention concerns extended release formulations comprising cisapride-(L)-tartrate, in particular an oral formulation, the use thereof as a medicine, especially in treating gastrokinetic disorders.
    Type: Grant
    Filed: October 18, 1999
    Date of Patent: August 14, 2001
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Eugene Marie Jozef Jans, Paul Marie Victor Gilis
  • Cisapride extended release
    Patent number: 6153623
    Abstract: The present invention concerns extended release formulations comprising cisapride-(L)-tartrate, in particular an oral formulation, the use thereof as a medicine, especially in treating gastrokinetic disorders.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: November 28, 2000
    Assignee: Janssen Pharmaceutic N.V.
    Inventors: Eugene Marie Jozef Jans, Paul Marie Victor Gilis
  • Extended release, film-coated tablet of astemizole and pseudoephedrine
    Patent number: 5681582
    Abstract: The present invention is concerned with an extended release, film coated tablet comprising as active ingredients the antihistaminic, antiallergic agent astemizole and the adrenergic, decongestant agent pseudoephedrine hydrochloride and with a process of preparing such tablets.
    Type: Grant
    Filed: November 8, 1995
    Date of Patent: October 28, 1997
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Paul Marie Victor Gilis, Eugene Marie Jozef Jans, Guido Jozef Maria Gijs